Live feed18:57:03·334dINSIDERFilingvia QuantisnowPresident and CEO Patel Dinesh V Ph D was granted 25,000 shares and sold $2,880,044 worth of shares (52,444 units at $54.92), decreasing direct ownership by 5% to 531,018 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.PTGX· Protagonist Therapeutics Inc.Health CareOriginal source